Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Mirum Pharmaceuticals Inc shares valued at $1,264,868 were sold by Brege Laura on Sep 11 ’25. At $74.40 per share, Brege Laura sold 17,000 shares. The insider’s holdings dropped to 15,703 shares worth approximately $1.16 million following the completion of this transaction.
Also, BJERKHOLT ERIC sold 9,578 shares, netting a total of over 728,024 in proceeds. Following the sale of shares at $76.01 each, the insider now holds 39,945 shares.
Before that, LAURA BREGE had added 17,000 shares to its account. In a trade valued at $1,264,917, the Director bought Mirum Pharmaceuticals Inc shares for $74.41 each.
As published in their initiating research note from TD Cowen on September 24, 2025, Mirum Pharmaceuticals Inc [MIRM] has been a Buy and the price target has been revised to $95. Earlier on April 17, 2024, Stifel initiated its rating. Their recommendation was “a Buy” for MIRM stock.
Analyzing MIRM Stock Performance
On last trading session, Mirum Pharmaceuticals Inc [NASDAQ: MIRM] plunged -0.93% to $73.57. The stock’s lowest price that day was $73.09, but it reached a high of $74.54 in the same session. During the last five days, there has been a drop of approximately -2.32%. Over the course of the year, Mirum Pharmaceuticals Inc shares have jumped approximately 88.98%. Shares of the company reached a 52-week high of $78.10 on 09/08/25 and a 52-week low of $36.88 on 04/09/25.
Support And Resistance Levels for Mirum Pharmaceuticals Inc (MIRM)
According to the 24-hour chart, there is a support level at 72.93, which, if violated, would cause prices to drop to 72.28. In the upper region, resistance lies at 74.38. The next price resistance is at 75.18. RSI (Relative Strength Index) is 56.38 on the 14-day chart, showing neutral technical sentiment.
Is Mirum Pharmaceuticals Inc subject to short interest?
Stocks of Mirum Pharmaceuticals Inc saw a sharp rise in short interest on 2025-08-29 jumping by 0.23 million shares to 6.86 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 6.63 million shares. A jump of 3.31% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.94 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.94.
Which companies own the most shares of Mirum Pharmaceuticals Inc (MIRM)?
In terms of Mirum Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 85 in the next 12 months, up nearly 14.46% from the previous closing price of $74.26. Analysts anticipate Mirum Pharmaceuticals Inc stock to reach 89 by 2025, with the lowest price target being 81. In spite of this, 9 analysts ranked Mirum Pharmaceuticals Inc stock as Buy at the end of 2025. On December 18, 2023, H.C. Wainwright assigned a price target of “a Buy” to the stock and reiterated coverage with a $58.
